Sample Size of Thorough QTc Clinical Trial Adjusted for Multiple Comparisons

REFERENCES

• Anand , S. P. , Murray , S. C. , Koch , G. ( 2010 ). Sample size calculations for crossover thorough QT studies: Satisfaction of regulatory threshold and assay sensitivity . Journal of Biopharmaceutical Statistics 20 ( 3 ): 563 – 579 .
   PubMed Web of Science ®Google Scholar
• Chow , S.-C. , Cheng , B. , Cosmato , D. (2008). On power and sample size calculation for QT studies with recording replicates at given time point. Journal of Biopharmaceutical Statistics 18(3):483–493.
   PubMed Web of Science ®Google Scholar
• Dong , X. , Ding , X. , Tsong , Y. ( 2013 ). Bayesian approach for assay sensitivity assessment of thorough QT clinical trial . Journal of Biopharmaceutical Statistics 23 ( 1 ): 73 – 81 .
   PubMed Web of Science ®Google Scholar
• Hosmane , B. , Locke , C. ( 2005 ). A simulation study of power in thorough QT/QTc studies and a normal approximation for planning purposes . Drug Information Journal 39 : 447 – 455 .
   Web of Science ®Google Scholar
• Hosmane , B. , Locke , C. , Chiu , Y.-L. ( 2010 ). Sample size and power estimation in thorough QT/QTc studies with parallel group design . Journal of Biopharmaceutical Statistics 20 ( 3 ): 595 – 603 .
   Web of Science ®Google Scholar
• Senn , S. , Bretz , F. ( 2007 ). Power and sample size when multiple endpoints are considered . Pharmaceutical Statistics 6 : 161 – 170 .
   PubMed Web of Science ®Google Scholar
• Tsong , Y. ( 2013 ). Advanced and adaptive designs of thorough QT clinical trials . Journal of Biopharmaceutical Statistics 23 ( 1 ): 43 – 56 .
   PubMed Web of Science ®Google Scholar
• Tsong , Y. , Zhong , J. ( 2010 ). Multiple comparisons of repeated measured responses: Issues of assessment of prolongation of QT interval in thorough QT trials . Journal of Biopharmaceutical Statistics 20 ( 3 ): 613 – 623 .
   Web of Science ®Google Scholar
• Tsong , Y. , Yan , L. L. , Zhong , J. , Nie , L. , Zhang , J. ( 2010 ). Multiple comparisons of repeated measured responses: Issues of validation testing in thorough QT/QTc clinical trials . Journal of Biopharmaceutical Statistics 20 ( 3 ): 654 – 664 .
   PubMed Web of Science ®Google Scholar
• Tsou , H.-H. , Tsong , Y. , Chang , W.-J. , Dong , X. , Hsiao , C.-F. ( 2012 ). Design and analysis . Journal of Biopharmaceutical Statistics 22 ( 5 ): 1051 – 1059 .
   PubMed Web of Science ®Google Scholar
• Yan , K. L. , Zhang , J. , Ng , M. J. , Dang , Q. ( 2010 ). Statistical summary of moxifloxacin induced QTc effect . Journal of Biopharmaceutical Statistics 20 ( 1 ): 497 – 507 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. ( 2008 ). Testing for positive control activity in a thorough QTc study . Journal of Biopharmaceutical Statistics 18 ( 1 ): 517 – 528 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. ( 2011 ). Optimal sample size allocation in a thorough QTc study . Drug Information Journal 45 : 455 – 468 .
   Web of Science ®Google Scholar
• Zhang , L. , Dmitrienko , L. G. ( 2008 ). Sample size calculation in thorough QT studies . Journal of Biopharmaceutical Statistics 18 ( 1 ): 468 – 482 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. , Machado , S. G. ( 2008 ). Statistical issues including design and sample size. Calculation in Thorough QT/QTc Studies . Journal of Biopharmaceutical Statistics 18 ( 1 ): 451 – 467 .
   PubMed Web of Science ®Google Scholar
• This article represents the point of views of the author. It does not necessarily represent the official position of U.S. FDA.
   Google Scholar